Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: worsened diffused pain; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 68 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 02Apr2021 (Lot number: ES0153) at the age of 68 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Mixed connective tissue disease", start date: 2017 (ongoing), notes: Pertinent details: ongoing diffused joint and muscle pain; "HTN", start date: 2017 (ongoing); "Hyperthyroidism", start date: 2012 (ongoing), notes: Pertinent details: Thyroid surgery; "Anxiety", start date: 2012 (ongoing); "Hyperlipidemia", start date: 2012 (ongoing); "Allergies: PCN [Penicillins]" (unspecified if ongoing), notes: Allergies: PCN [Penicillins] - (reactions not documented); "Allergies: Seafood" (unspecified if ongoing), notes: Allergies: Seafood - (reactions not documented); "Allergies: Sulfa drugs" (unspecified if ongoing), notes: Allergies: Sulfa drugs (reactions not documented); "Allergies: Adhesive Tape" (unspecified if ongoing); "Allergies: Adhesive Tape - Rash" (unspecified if ongoing); "congestion" (unspecified if ongoing); "dry eyes" (unspecified if ongoing); "pain" (unspecified if ongoing); "sleep" (unspecified if ongoing); "nausea" (unspecified if ongoing); "vomiting" (unspecified if ongoing). Concomitant medication(s) included: CITRACAL [CALCIUM CITRATE]; CELEBREX; KLONOPIN taken for anxiety; COLACE; VIVELLE-DOT; LUNESTA; PLAQUENIL [HYDROXYCHLOROQUINE PHOSPHATE]; ATARAX [HYDROXYZINE HYDROCHLORIDE] taken for nasal congestion; SYNTHROID; LIDODERM; TOPROL XL; MILK THISTLE; BENICAR; LOVAZA taken for dry eye; PRILOSEC [OMEPRAZOLE]; OXAYDO taken for pain; COMPAZINE [PROCHLORPERAZINE MALEATE] taken for nausea, vomiting; AMBIEN CR taken for sleep disorder. Past drug history included: Aspirin, reaction(s): "Allergies: Aspirin [Dihydroxyaluminum Aminoacetate]", notes: Allergies: Aspirin [Dihydroxyaluminum Aminoacetate] - Hives; Aspirin, reaction(s): "Allergies: Hives", notes: Allergies: Aspirin [Dihydroxyaluminum Aminoacetate] - Hives; Gabapentin, reaction(s): "Allergies"; Trazodone, reaction(s): "Allergies"; Wellbutrin, reaction(s): "Allergies". Vaccination history included: Prevnar 13 (Allergies: Prevnar 13 (Pneumococcal 13-VAL CONJ Vacc] - Rash), reaction(s): "Allergies: Prevnar 13 (Pneumococcal 13-VAL CONJ Vacc] - Rash", "Allergies: Prevnar 13 (Pneumococcal 13-VAL CONJ Vacc] - Rash". The following information was reported: PAIN (non-serious) with onset 03Apr2021, outcome "recovering", described as "worsened diffused pain". The event "worsened diffused pain" was evaluated at the physician office visit. Therapeutic measures were taken as a result of pain.  Additional Information: The patient also received bnt162b2 (BNT162B2), administered on Left Arm, administration date 23Apr2021 (Lot number: EW0172) at the age of 68 years as dose 2, single for covid-19 immunisation. The patient has no prior vaccination within 4 weeks. The patient received prednisone as treatment for adverse event.   No follow-up attempts are possible. No further information is expected.